Table 2.
Factors found to affect severe adverse events in patients with IgAN on multivariable logistic regression analyses
| Multivariable analysis |
||
|---|---|---|
| OR (95%CI) | P value | |
| Age (yr) | 1.05 (1.03–1.07) | <0.001 |
| Sex (female) | 1.52 (0.88–2.62) | 0.131 |
| Mean arterial pressure (mm Hg) | 1.03 (1.01–1.05) | 0.010 |
| Proteinuria (g/24 h) | 1.02 (0.93–1.12) | 0.650 |
| eGFR (ml/min per 1.73 m2) | 1.01 (0.99–1.02) | 0.905 |
| Corticosteroid therapy | ||
| Noncorticosteroid therapy | Reference | - |
| Corticosteroid alone | 4.13 (1.97–8.67) | <0.001 |
| Corticosteroid plus immunosuppressant | 6.34 (3.43–11.72) | <0.001 |
Bold values are statistically significant.
CI, confidence interval; eGFR, estimated glomerular filtration rate; OR, odds ratio.